Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients

被引:56
作者
Baumhaekel, M. [1 ]
Boehm, M. [1 ]
机构
[1] Univ Saarlandes Kliniken, Innere Med Klin 3, D-66421 Homburg, Germany
关键词
D O I
10.1111/j.1742-1241.2006.01274.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Erectile dysfunction (ED) is related to cardiovascular risk factors by an impairment of endothelial function. Therefore, symptoms of ED are probably to precede cardiovascular disease and events. Moreover, endothelial dysfunction is common in patients with decreased left ventricular ejection fraction (LVEF). Hence, left ventricular dysfunction probably results in a decreased erectile function. A total of 192 cardiovascular high-risk patients from the EROSS Programme (Evaluation of Role of Sexual Dysfunction in the Saarland Programme) were evaluated regarding onset and severity of ED using the IIEF-5 questionnaire. LVEF was measured with magnetic resonance imaging, angiographically or echocardiographically. Prevalence of ED was 80.6%. Patients with moderate or severe impairment of ejection fraction had a significant increase of ED (p = 0.001). Multivariate analysis identified LV dysfunction as an independent risk factor for ED independent of heart failure symptoms (p = 0.001). Moreover, symptoms of ED appeared 3.04 +/- 7.2 years prior to the cardiovascular event (p = 0.005). LVEF is an independent risk factor for the development or increase of ED in cardiovascular high-risk patients, probably caused by an impairment of endothelial function. Hence, ED is suggested to be an early symptom of generalised cardiovascular disease and events. Thus, cardiovascular evaluation is recommended in patients with ED providing the opportunity of optimised preventional treatment.
引用
收藏
页码:361 / 366
页数:6
相关论文
共 29 条
[1]   The impact of first-line antihypertensive drugs on erectile dysfunction [J].
Barksdale, JD ;
Gardner, SF .
PHARMACOTHERAPY, 1999, 19 (05) :573-581
[2]   Endothelial dysfunction: its role in hypertensive coronary disease [J].
Bolad, I ;
Delafontaine, P .
CURRENT OPINION IN CARDIOLOGY, 2005, 20 (04) :270-274
[3]   Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey' [J].
Braun, M ;
Wassmer, G ;
Klotz, T ;
Reifenrath, B ;
Mathers, M ;
Engelmann, U .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2000, 12 (06) :305-311
[4]   Captopril treatment reverses erectile dysfunction in male stroke prone spontaneously hypertensive rats [J].
Dorrance, AM ;
Lewis, RW ;
Mills, TM .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2002, 14 (06) :494-497
[5]   Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men [J].
Düsing, R .
BLOOD PRESSURE, 2003, 12 :29-34
[6]   Heart failure, redox alterations, and endothelial dysfunction [J].
Farré, AL ;
Casado, S .
HYPERTENSION, 2001, 38 (06) :1400-1405
[7]   Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts Male Aging Study [J].
Feldman, HA ;
Johannes, CB ;
Derby, CA ;
Kleinman, IC ;
Mohr, BA ;
Araujo, AB ;
McKinlay, JB .
PREVENTIVE MEDICINE, 2000, 30 (04) :328-338
[8]   IMPOTENCE AND ITS MEDICAL AND PSYCHOSOCIAL CORRELATES - RESULTS OF THE MASSACHUSETTS MALE AGING STUDY [J].
FELDMAN, HA ;
GOLDSTEIN, I ;
HATZICHRISTOU, DG ;
KRANE, RJ ;
MCKINLAY, JB .
JOURNAL OF UROLOGY, 1994, 151 (01) :54-61
[9]   Sexual function in hypertensive males treated with lisinopril or atenolol - A cross-over study [J].
Fogari, R ;
Zoppi, A ;
Corradi, L ;
Mugellini, A ;
Poletti, L ;
Lusardi, P .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (10) :1244-1247
[10]   Sexual activity in hypertensive men treated with valsartan or carvedilol: A crossover study [J].
Fogari, R ;
Zoppi, A ;
Poletti, L ;
Marasi, G ;
Mugellini, A ;
Corradi, L .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (01) :27-31